Dr. Kenneth Zemanek, MD

Dr. Zemanek practices at Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University.

Dr. Zemanek's NPI, 1558316174, was assigned on May 23, 2006. Dr. Zemanek graduated from Rutgers Robert Wood Johnson Medical School in 1986. Dr. Zemanek holds Pennsylvania license MD041745L.

Dr. Zemanek's primary practice is Lehigh Valley Hospital-Cedar Crest, at 1200 South Cedar Crest Boulevard, Allentown, PA 18103 in Lehigh County. The practice phone is (610) 402-8000.

Dr. Zemanek's primary practice is Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University. Dr. Zemanek is also affiliated with Lehigh Valley Hospital-Hazleton. The medical group on file is Lehigh Valley Physician Group (LVPG). Dmand AI also links Dr. Zemanek to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zemanek practices, 5 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Zemanek's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Zemanek is board certified in addiction psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Zemanek's licenses on file in 2 states: Pennsylvania and New Jersey.

Dmand AI lists ADHD, alcohol use disorders, anxiety, bipolar disorder, depression, insomnia and schizophrenia among the conditions Dr. Zemanek treats.

CMS data shows 1,463 Medicare services from Dr. Zemanek across 8 procedure codes in 2024, for 336 Medicare patients. Medicare paid $77,658 for them.

CMS counts 336 Medicare patients who saw Dr. Zemanek in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high cholesterol, and 75% have mood disorders. 29% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zemanek's median patient age at 62, with 55% women.

In 2024, Dr. Zemanek wrote 8,199 Medicare Part D claims for 428 patients. 96% of them were for generic drugs. CMS names the drug for 7,967 of them, across 82 drugs with 11 or more claims each, at $847,588 in total drug cost. In 2023, CMS named 7,311 claims across 85 drugs.

Dr. Zemanek accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zemanek as offering telehealth.

Dmand AI links 1 paper to Dr. Zemanek in 2012. Dr. Zemanek's most frequent co-authors are Michael W. Kaufmann, MD, Edward Robert Norris, MD and Ralph A. Primelo, MD.

CMS Open Payments shows 402 general payments to Dr. Zemanek from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $3,528.

Dr. Zemanek graduated from Rutgers Robert Wood Johnson Medical School in 1986.

Dr. Zemanek is in network with 20 carriers, including Aetna, HCSC and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.